SCR-LIP-000231 · Claim · machine-readable JSON →
This review proposes AKR1C enzymes (AKR1C1-4) as a central biological pathway linking rare familial mutations (e.g., AKR1C1 L213Q segregating with lipedema across 3 generations, AKR1C2 Ser320PheTer2) and common regulatory polymorphisms (rs28571848, rs34477787) to lipedema through altered steroid hormone metabolism in gluteofemoral subcutaneous adipose tissue, with environmental endocrine disruptors and hormones converging on the same hereditary pathway.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- From rare familial mutations to multifactorial disease: aldo-keto reductase 1C enzymes as a central biological pathway in lipedema — Vainberg et al. (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“Variante AKR1C1 p.Leu213Gln (L213Q) — descrita por Michelini et al. — segrega com lipedema em 3 gerações”
Review articulating a gene-environment model in which both heredity (familial AKR1C mutations and regulatory polymorphisms) and hormones (steroid metabolism, endocrine disruptors) influence lipedema onset, directly supporting the question's
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? consistent
- Do hormonal factors (puberty, pregnancy, menopause, estrogen) trigger or influence lipedema onset? consistent
- Is lipedema onset influenced by heredity and family history? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000012